Study number 8520-284
Dates
Dec 12 2023-Dec 26 2023
Location
Dallas, Texas
Age
18-55
Gender
Both
Smoker
Compensation
$5,195
Group
4
The study drug is an investigational drug being developed to treat and slow the progression of Alzheimer's disease (AD).
The purpose of this study is to measure how much of the study drug and its breakdown products get into the bloodstream, and how long it takes the body to get rid of them, when given as two different tablet formulations. In addition, the safety and tolerability of the study drug will be evaluated.
Fortrea Dallas, TX is recruiting for: - Healthy Adults, age 18-55
- Healthy Adults, age 18-55
- Body Mass Index between 18-32
- Study involves 1 stay of 10 nights, plus 1 follow-up call
- Compensation up to $5,195 may be provided for time and participation
- Refer a friend to receive up to $300 per qualified referrall
Cohort 4:
Check-in: Dec 12
Check-out: Dec 22
Call: Dec 26